📄 Cross-examination of Dr. Robin Cotton (part 1) — Friday, May 12, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\12\CROSS-EXAMINATION-OF-DR-ROBIN-.DOC
TRIAL
▲ Day 73 of 167

Cross-examination of Dr. Robin Cotton (part 1)

Witness: Dr. Robin Cotton
Examiner: Peter Neufeld
Called by: Prosecution • Date: Friday, May 12, 1995 • Utterances: 577
Defense attorney Peter Neufeld continued his cross-examination of Cellmark laboratory director Dr. Robin Cotton, systematically attacking both the financial bias of Cellmark as a for-profit DNA testing business and the absence of mandatory federal regulation over forensic DNA laboratories. Neufeld then shifted to challenging the handling of biological evidence — specifically whether wet blood swatches stored in sealed plastic bags in a hot, unrefrigerated truck for up to seven hours would accelerate DNA degradation — using photographs of the actual Bundy swatches to illustrate differences in DNA quality between samples.
1 (The following proceedings were held in open court:)
2 THE COURT:

All right. Good morning, ladies and gentlemen. Dr. Cotton, good morning. Would you resume the witness stand, please.

Robin Cotton, the witness on the stand at the time of the evening adjournment, resumed the stand and testified further as follows:

3 THE COURT:

Good morning again, Dr. Cotton. You are reminded, ma'am, you are still under oath. And Mr. Neufeld, you may continue with your cross-examination.

4 MR. NEUFELD:

Thank you. Good morning ladies and gentlemen.

THE JURY: Good morning.

CROSS-EXAMINATION (RESUMED) BY MR. NEUFELD

5 MR. NEUFELD:

Good morning, Dr. Cotton.

6 DR. COTTON:

Good morning.

7 MR. NEUFELD:

Dr. Cotton, you may recall late yesterday afternoon I showed you a letter which has been marked as Defense exhibit 1145?

8 DR. COTTON:

Yes, I do.

9 MR. NEUFELD:

Okay. And my question simply is--you read that letter yesterday?

10 DR. COTTON:

I read it last night.

11 MR. NEUFELD:

Okay. All right. And having read this five-page letter, the question simply is this: Did you rely on this letter at all when you testified yesterday earlier that there were simply a handful, or I'm sorry, a few members of the scientific community who took issue with the appropriateness of using the assumptions about the independence of inherited genetic traits that you use in forensic DNA typing?

12 MR. CLARKE:

Objection, misstates the evidence.

13 THE COURT:

Sustained. Doctor, with regards to this letter, did you consider this letter in any way in forming your opinions that you have given us thus far?

14 DR. COTTON:

No, I did not.

15 MR. NEUFELD:

Thank you.

16 MR. NEUFELD:

Now, I noticed yesterday Dr. Cotton, that you had your own copy of the national academy of science book "DNA technology in forensic science"; is that right?

17 DR. COTTON:

Yes, I do.

18 MR. NEUFELD:

Are you familiar with some of the members who are on that committee that authored this book?

19 DR. COTTON:

Yes.

20 MR. NEUFELD:

Are you familiar with the Chairman of this committee Victor Mckusick?

21 DR. COTTON:

Yes, I am.

22 MR. NEUFELD:

Okay.

23 MR. CLARKE:

Excuse me. Objection, relevance.

24 THE COURT:

Overruled.

25 MR. NEUFELD:

And quite simply, is Victor McKusick known as one of the leading geneticists in America?

26 MR. CLARKE:

Excuse me. Same objection.

27 THE COURT:

Overruled.

28 DR. COTTON:

Yes, I think he is.

29 MR. NEUFELD:

In fact, he is the founding president of the human geno organization, isn't he?

30 DR. COTTON:

That I don't know.

31 MR. NEUFELD:

Would it help if you looked at the biographical information on committee members contained in the back of the book?

32 THE COURT:

That is hearsay, counsel. He is the chairman of the committee. I think that establishes who he is.

33 MR. NEUFELD:

And are you familiar with another member of the committee, Paul Ferrara?

34 DR. COTTON:

Yes.

35 MR. NEUFELD:

And do you know that Paul Ferrara is the director of the Virginia Division of Forensic Science?

36 DR. COTTON:

Yes. And he is also the director of the ASCLAD lab accreditation group.

37 MR. NEUFELD:

And I take it that he is someone whose opinions you respect?

38 DR. COTTON:

That's correct.

39 MR. NEUFELD:

And would the same also apply for Dr. McKusick who is the chairman of the committee? Are his opinions those that you would respect?

40 DR. COTTON:

I guess it would depend on his opinion about any particular issue.

41 MR. NEUFELD:

His opinions about molecular biology and genetics?

42 MR. CLARKE:

Objection, relevance.

43 THE COURT:

Overruled.

44 DR. COTTON:

Despite the fact that he is a very well-known scientist, he may have an opinion on a single issue that I might not agree with and an opinion on another issue that I might, so I can't make a blanket statement that I would agree with every opinion that Dr. McKusick would have.

45 MR. NEUFELD:

Would you regard Paul Ferrara as an expert in the area of forensic science?

46 DR. COTTON:

Yes.

47 MR. NEUFELD:

And would you regard him as an expert in the application of DNA profiling in forensic science?

48 DR. COTTON:

No, I don't think so.

49 MR. NEUFELD:

Would you regard him as an expert in establishing the proper controls and quality assurance for handling items of biological evidence that will subsequently be tested on a DNA level?

50 DR. COTTON:

Yes.

51 MR. NEUFELD:

And are you familiar with another member of the committee, Dr. Haig Kazazian?

52 DR. COTTON:

Yes.

53 MR. NEUFELD:

And are you aware that he is the director of the Center of Medical Genetics at Johns Hopkins University School of Medicine?

54 DR. COTTON:

Yes.

55 THE COURT:

Do you want to spell that for the court reporter.

56 MR. NEUFELD:

K-A-Z-A-Z-I-A-N. First name Haig, H-A-I-G.

57 MR. NEUFELD:

And is it Haig Kazazian's reputation that he is one of the leading members of the genetics community in this country?

58 DR. COTTON:

Yes.

59 MR. NEUFELD:

And are you familiar with Dr. Mary-Clair King?

60 DR. COTTON:

Yes.

61 MR. NEUFELD:

And are you aware that she is a Professor of Epidemiology in the School of Public Health at the University of California at Berkeley?

62 DR. COTTON:

Yes.

63 MR. NEUFELD:

And that she has a reputation in the community of population genetics?

64 DR. COTTON:

I know--

65 MR. CLARKE:

Excuse me. Objection, vague.

66 THE COURT:

Overruled. Dr. Cotton.

67 DR. COTTON:

I know that she is interested in population genetics and I have met her on a couple of occasions. I don't know what her overall scientific reputation within her field is.

68 MR. NEUFELD:

And are you familiar with another member of the committee, Dr. Henry C. Lee?

69 DR. COTTON:

Yes.

70 MR. NEUFELD:

And would you agree that Dr. Lee is one of the--I'm sorry--are you aware that he is the director of the forensic science laboratories of the Connecticut State Police?

71 DR. COTTON:

Yes, I am.

72 MR. NEUFELD:

Are you aware that he is also a Professor of Forensic Science in Connecticut?

73 DR. COTTON:

Yes.

74 MR. NEUFELD:

And would you agree that his reputation is of being one of the leading forensic scientists in America?

75 DR. COTTON:

Yes.

76 MR. NEUFELD:

Finally, are you familiar with this other member of the committee, Dr. George Sensabaugh?

77 DR. COTTON:

Yes.

78 MR. NEUFELD:

And Dr. Sensabaugh, are you aware that Dr. Sensabaugh is a Professor of Forensic Science and Biomedical Sciences also at the University of California at Berkeley?

79 DR. COTTON:

Yes.

80 MR. NEUFELD:

And in fact, this member of the committee, Dr. Sensabaugh, has from time to time been a paid consultant to Cellmark, hasn't he?

81 DR. COTTON:

I don't really--I know that he has consulted with Cellmark back in like 1988. I don't really recall whether he was paid or he just agreed to do that. And he hasn't consulted specifically for us in any way for quite a long time.

82 MR. NEUFELD:

And would it be fair to say that you certainly--that he has a very excellent reputation in the forensic science community?

83 DR. COTTON:

Yes, I would.

84 MR. NEUFELD:

Would you also consider him an expert in the application of DNA profiling to forensic specimens?

85 DR. COTTON:

Yes, I think so.

86 MR. NEUFELD:

And would you respect his opinions and conclusions on those topics?

87 MR. CLARKE:

Objection, relevance.

88 THE COURT:

Well, that is vague.

89 MR. NEUFELD:

Now, to your knowledge, Dr. Cotton, do any of the scientists or forensic scientists who I have named who served on this committee and authored this book, to your knowledge do any of them have a financial interest in any laboratory conducting forensic DNA typing?

90 MR. CLARKE:

Objection, relevance.

91 THE COURT:

Sustained.

92 MR. NEUFELD:

Does Cellmark have a financial interest in the outcome of the controversy over the proper methods to estimate the frequency after DNA pattern?

93 MR. CLARKE:

Objection, relevance, hearsay and assumes facts not in evidence.

94 THE COURT:

Sustained.

95 MR. NEUFELD:

Goes to bias.

96 THE COURT:

Sustained. Rephrase the question, counsel. Financial compensation is fair game, but the manner in which it is phrased is not appropriate. Rephrase the question.

97 MR. NEUFELD:

Well, Cellmark is not a government laboratory, is it?

98 DR. COTTON:

No, it is not.

99 MR. NEUFELD:

Cellmark is not a not-for-profit research laboratory, is it?

100 DR. COTTON:

No, it is not.

101 MR. NEUFELD:

Cellmark is in the business of doing DNA testing for hire; isn't that right?

102 MR. CLARKE:

Well, objection. I think that is argumentative.

103 THE COURT:

It is. Rephrase the question.

104 MR. NEUFELD:

Cellmark--Cellmark--Cellmark diagnostics laboratory is a business operation, isn't it?

105 DR. COTTON:

Yes, it is.

106 MR. NEUFELD:

All right. And not only do you charge for the actual testing that you do, for instance, for the Prosecution in this case, but you are paid, for instance, by the Prosecution for your attendance here as an expert witness; isn't that right?

107 DR. COTTON:

Cellmark is paid for my attendance here.

KEY QUOTE
108 MR. NEUFELD:

Right.

109 DR. COTTON:

I don't get paid.

110 MR. NEUFELD:

Cellmark is paid for your attendance as an expert witness?

111 DR. COTTON:

That's right.

112 MR. NEUFELD:

Do you know how much Cellmark receives each day for your attendance here?

113 DR. COTTON:

Yes, I do.

114 MR. NEUFELD:

How much is that?

115 DR. COTTON:

It is $1200.

116 MR. NEUFELD:

And are those for the days that you are actually on the witness stand or is Cellmark charging $1200 a day when you are simply sitting here in court or upstairs in the District Attorney's office?

117 DR. COTTON:

Well, if I'm here on business for a particular case, then whatever I'm doing on that business, whether I'm upstairs or down here, is still time away from the lab and so it is still charged at that same rate.

118 MR. NEUFELD:

All right. You said that you are the laboratory director for Cellmark in the USA; is that right?

119 DR. COTTON:

Yes, I am.

120 MR. NEUFELD:

You mentioned at the close of your direct examination, Dr. Cotton, that you furnished the Defense copies of your protocol and databases in this case; is that right?

121 DR. COTTON:

Yes.

122 MR. NEUFELD:

Now, when you said you furnished copies of your databases as discovery, did you mean that you furnished the actual x-ray films comprising those databases or did you furnish us with computer disks which reflect the sizings of the various people who are in your database?

123 DR. COTTON:

It was the computer disk that reflect the sizings.

124 MR. NEUFELD:

And in fact, Dr. Cotton, in furnishing such items as the protocols and the databases, you charge the Defense for those items, didn't you?

125 DR. COTTON:

Yes, we did.

126 MR. NEUFELD:

And would it be fair to say, Dr. Cotton, that for the discovery that we have asked for in this case and received you have charged the Defense more than $5,000?

127 DR. COTTON:

That's correct.

128 MR. NEUFELD:

And that is another way that Cellmark can make money from being retained in a particular case?

129 MR. CLARKE:

Objection, argumentative.

130 THE COURT:

Sustained. Rephrase the question.

131 MR. NEUFELD:

Well, for instance, Dr. Cotton, for the various copies of x-ray films of autorads that we have requested in this case as discovery, you charge $25.00 an autorad; is that right?

132 DR. COTTON:

That's correct except--

133 MR. NEUFELD:

Would you--I'm sorry.

134 DR. COTTON:

Can I finish, please?

135 MR. NEUFELD:

Yes.

136 DR. COTTON:

We did not charge for the copies of the case films.

137 MR. NEUFELD:

But for the other autorads that we requested for discovery purposes to assess the quality of your laboratory, you charged $25.00 for each of those?

138 DR. COTTON:

That's correct.

139 MR. NEUFELD:

And do you know, for instance, that the Department of Justice charges $5.00 for each of those x-ray films?

140 MR. CLARKE:

Objection, calls for hearsay, irrelevant.

141 THE COURT:

Sustained. Assumes facts not in evidence.

142 MR. NEUFELD:

Well--

143 THE COURT:

Rephrase the question.

144 MR. NEUFELD:

Do you know how much the Department of Justice charges?

145 THE COURT:

Rephrase the question.

146 MR. NEUFELD:

--the Defense for each x-ray film that it produces in this case?

147 THE COURT:

Rephrase the question. It is vague.

148 MR. NEUFELD:

It is vague?

149 THE COURT:

It is vague.

150 MR. NEUFELD:

Okay.

151 THE COURT:

There are 28 Departments of Justice in the United States.

152 MR. NEUFELD:

Okay.

153 MR. NEUFELD:

Do you know how much the California Department of Justice DNA laboratory charges the Defense for each autorad that it produces in this case?

154 DR. COTTON:

No, I don't.

155 MR. CLARKE:

Objection, irrelevant.

156 THE COURT:

Overruled.

157 MR. NEUFELD:

Now, when we finished yesterday afternoon, I asked you a few questions about this--this notion of the transfer of technology from medical diagnostics or disease diagnostics to the forensic case. Do you recall that?

158 DR. COTTON:

Yes.

159 MR. NEUFELD:

And I believe at the end, just to make the transition, your Honor, that you agree that new applications such as forensics may present or pose more problems which may affect the reliability of the new application; is that correct?

160 DR. COTTON:

Well, I believe what I said was that any new application may pose more problems or less problems than some previous application, so you can't assume, just because it is a new application, that already it has more problems.

161 MR. NEUFELD:

All right. Currently, Dr. Cotton, would you agree that there is no federal regulatory scheme requiring that you meet certain minimal quality for your forensic DNA profiling at your laboratory? Would you agree with that fact, with that statement?

162 DR. COTTON:

Can you clarify that? What do you mean by a federal --

163 MR. NEUFELD:

Sure.

164 DR. COTTON:

--scheme?

165 MR. NEUFELD:

There is no federal regulation that regulates the quality of forensic DNA profiling that you generate in your laboratory currently; isn't that correct?

166 DR. COTTON:

Yes. That would apply to all forensic DNA typing laboratories. There are no federal--specific federal regulations applying to forensic DNA laboratories.

167 MR. NEUFELD:

On the other hand, do you know whether, for instance, the national bone marrow program DNA typing procedures are subjected to mandatory federal regulations which govern the quality of their testing?

168 DR. COTTON:

Not--no, I don't know.

169 MR. NEUFELD:

Okay. Would you agree in fact that currently, Dr. Cotton, there is more federal regulatory control of the quality in testing for strep throat than there is in the quality of testing for forensic DNA profiling?

170 MR. CLARKE:

Objection, irrelevant.

171 THE COURT:

Sustained.

172 MR. NEUFELD:

Now, you mentioned on direct examination that you have been accredited by the American Society of Crime Lab Directors L.A.B.; is that right?

173 DR. COTTON:

Yes, I did.

174 MR. NEUFELD:

And this is a voluntary program, is it not?

175 DR. COTTON:

Yes, it is.

176 MR. NEUFELD:

Do you know whether in the field of DNA--DNA's clinical applications in medicine whether accreditation is mandatory by law?

177 MR. CLARKE:

Objection, irrelevant.

178 THE COURT:

Sustained.

179 MR. NEUFELD:

At forensic laboratories that do DNA profiling, is external blood proficiency testing mandatory?

180 DR. COTTON:

Since there is no regulation, there is nothing to be mandatory. There are guidelines that suggest that that would be a good thing to do, if possible. It is difficult to do--I don't know about other laboratories. We to do some external blind tests, but not very many.

181 MR. NEUFELD:

Do you have any knowledge to what extent the Los Angeles Police Department DNA laboratory submits to blind external proficiency testing?

182 MR. CLARKE:

Objection, irrelevant, calls for hearsay.

183 THE COURT:

Sustained.

184 MR. NEUFELD:

Unlike for forensic DNA laboratories, do you have knowledge whether the laboratories that do the bone marrow typing are subjected to mandatory external blind proficiency testing?

185 MR. CLARKE:

Objection. Irrelevant, assumes facts not in evidence.

186 THE COURT:

Sustained.

187 MR. NEUFELD:

To her knowledge.

188 THE COURT:

Sustained.

189 MR. NEUFELD:

Now, was becoming accredited by ASCLAD important to you and to Cellmark?

190 DR. COTTON:

Yes, it was.

191 MR. NEUFELD:

And would you agree that one of the principal purposes of accreditation is to improve the quality of forensic laboratory services?

192 DR. COTTON:

No, I--that's not why we--I can only speak for why we sought accreditation. I can't speak for why another laboratory would do that.

193 MR. NEUFELD:

Why don't you tell us why you sought accreditation, Dr. Cotton?

194 DR. COTTON:

We wanted to have a clear demonstration and that our laboratory work had been--was meeting the TWGDAM guidelines and other guidelines that were set forth by ASCLAD, and therefore we sought the--we applied and sought the accreditation.

195 MR. NEUFELD:

Would you agree that one of the reasons that you wanted to demonstrate that you met the ASCLAD guidelines is to show the public that they can have confidence in the results generated by your laboratory?

196 MR. CLARKE:

Objection, argumentative, your Honor.

197 THE COURT:

Overruled.

198 DR. COTTON:

Yes.

199 MR. NEUFELD:

And I believe you said that for a laboratory such as your own to get accredited by ASCLAD the laboratory had to be inspected by qualified and independent laboratory managers and scientists?

200 DR. COTTON:

That's right.

201 MR. NEUFELD:

And every aspect of your laboratory's operations was inspected and evaluated?

202 DR. COTTON:

That's right.

203 MR. NEUFELD:

And I believe you also said on direct examination that whereas you are the first private laboratory doing forensic DNA profiling to be accredited, that there were many others in the sub-sector, namely, local or State University laboratories that were accredited by ASCLAD? Do you recall that?

204 DR. COTTON:

There are--to my understanding there is about twenty or so.

205 MR. NEUFELD:

And to your knowledge understanding, Dr. Cotton, the Los Angeles Police Department is not one of them; isn't that right?

206 MR. CLARKE:

Objection, irrelevant.

207 THE COURT:

Sustained.

208 MR. NEUFELD:

Now, I believe you said, Dr. Cotton, on direct examination, that each laboratory setting out to do DNA profiling must go through its own validation and make sure that its own people can do it well before going on line with case work; is that correct?

209 DR. COTTON:

I don't remember whether I said anything regarding that yesterday or not.

210 MR. NEUFELD:

Well, would you agree--well, whether or not you said it then, would you agree with that statement?

211 DR. COTTON:

Yes, basically I would.

212 MR. NEUFELD:

Would you agree that it is essential that before a laboratory goes on line doing DNA case work that it gain familiarity with the system by using fresh samples?

213 DR. COTTON:

Yes, that seems like a good idea.

214 MR. NEUFELD:

And would you agree that another thing that a laboratory should do before it goes on line with a particular DNA procedure is to test the marker's survival in dried stains? When I say "The marker," I mean the DNA probes that you are using?

215 DR. COTTON:

What do you mean by "Marker survival"?

216 MR. NEUFELD:

Well, to see how well it does with dried bloodstains, as opposed to fresh blood, for instance?

217 DR. COTTON:

Sure.

218 MR. NEUFELD:

Its robustness?

219 DR. COTTON:

Sure.

220 MR. NEUFELD:

And would you agree that it is important, as a precondition to going on line, that the forensic laboratory test the system on simulated evidence samples have been exposed to a variety of environmental conditions, such as heat and humidity and sunlight and the rest?

221 DR. COTTON:

No.

222 MR. NEUFELD:

You don't think that is important?

223 DR. COTTON:

Well, it is important that that be done at some point, but I don't see any reason why every forensic laboratory should have to do that. If that has been done and that work has been published, I see no need for any laboratory to go back and do that same work over and over and over again every time a laboratory is about to come on line with a new test.

224 MR. NEUFELD:

All right. Would you agree that it is important that the new laboratory, before it goes on line, test its own system on non-probative evidence samples whose origin is known, simply as a check on reliability?

225 DR. COTTON:

Yes.

226 MR. NEUFELD:

And finally, Dr. Cotton, would you agree that before a new laboratory goes on line with this technology that it is important that it establish basic--that it establish basic competence in using the system through blind trials?

227 DR. COTTON:

No.

228 MR. NEUFELD:

Could you please explain to the jury what blind trials are.

229 DR. COTTON:

Yes, and I think there is sometimes many definitions.

230 (Brief pause.)
231 (Power outage in the courtroom.)
232 THE COURT:

All right. Mr. Neufeld. All right. Mr. Neufeld, you had just asked Dr. Cotton to explain to the jury what blind trials are.

233 MR. NEUFELD:

Thank you.

234 THE COURT:

You are welcome.

235 DR. COTTON:

What I'm going to do is try to explain--use some words so that maybe we are all using the same words. If you get a proficiency test into the lab, generally the laboratory staff is aware that that is a proficiency test. They are not aware of what the answer should be, but they are aware that this is a set of proficiency samples. In answer to Mr. Neufeld's question, if you have a blind proficiency test, that would mean that the laboratory staff would not know that that was a proficiency test sample. That means it has to come submitted as a regular case with a letter of submission, a person of contact, and all the other things that come with a regular case submission, so it has to look like a fake case. And when the laboratory analyst reaches the point where they would call up and say I have enough DNA to proceed or I don't have enough DNA to proceed, there has to be a person who is willing to talk to them and continue to behave as if this is a real case. So finding outside people to assist you in setting up a blind proficiency test is difficult. There are, however, plenty of proficiency test providers for a non-blind test.

236 MR. NEUFELD:

So you would disagree with that statement that I just made about the necessity of blind trials before a laboratory goes on line?

237 DR. COTTON:

Yes. I would agree that laboratories should do a proficiency test before they go on line, but I would not agree that it needs to be a blind proficiency test, because if they are not on line, how can they be accepting a case in the first place, so I don't even see how you would exactly do that.

238 MR. NEUFELD:

All right. Dr. Cotton, let me ask you this: Even once they go on line, would you agree that there is no substitute in assessing the quality of the work generated by the laboratory to engage in rigorous external proficiency testing via blind trials on a regular basis?

239 MR. CLARKE:

Objection. Assumes facts not in evidence.

240 THE COURT:

It is argumentative. Sustained.

241 MR. NEUFELD:

Dr. Cotton, in arriving at your opinions on this particular matter, did you read the section of the NRC report entitled "Experimental foundation"?

242 DR. COTTON:

If I could just look quickly at the--

243 MR. NEUFELD:

Page 55 in your book.

244 DR. COTTON:

Can you ask your question again now?

245 MR. NEUFELD:

Fine. In arriving at your opinions as to what a laboratory should do as a precondition before using new DNA typing, did you at all rely on that section of the national academy of science's book "DNA technology in forensic science"?

246 DR. COTTON:

No.

247 MR. NEUFELD:

Okay. Now, in your laboratory, I think you mentioned that there are several molecular biologists who process the evidence when it comes in and then analyze the evidence; is that correct?

248 DR. COTTON:

That's right.

249 MR. NEUFELD:

And do these molecular biologists begin handling the evidence from the moment it arrives or are there other people with less training who do the initial processing of evidence when it comes to the laboratory?

250 DR. COTTON:

No. They begin handling the evidence from the point that it is unpackaged.

251 MR. NEUFELD:

When we talk about unpackaging, we are talking about unpackaging the blood swatches or other types of material that you get from a police department laboratory or wherever?

252 DR. COTTON:

That's right.

253 MR. NEUFELD:

All right. And I think you mentioned that each of your molecular biologists who begin the processing of the evidence, at least in this case, have six years' experience; is that right?

254 DR. COTTON:

No. They don't all have six years' of experience. It happens that the two people who worked on this case have six years of experience.

255 MR. NEUFELD:

That would be Cooper and Yates?

256 DR. COTTON:

That's right.

257 MR. NEUFELD:

And however, all these molecular biologists who process the evidence from inception--from its arrival, excuse me, are supervised by several ph.D.s; is that right?

258 DR. COTTON:

They are directly by--they are directly supervised by one of the their own group and then indirectly supervised in terms of the case's review by the Ph.D. staff and they are supervised by myself.

259 MR. NEUFELD:

And how many ph.D.s are there in the Ph.D. staff at Cellmark?

260 DR. COTTON:

Well, there are four people with a Ph.D. with Cellmark, but three of them are involved in assigning cases.

261 MR. NEUFELD:

Do you have any knowledge at all about the extent of the experience of the criminalists who are processing these items of evidence at the Los Angeles Police Department?

262 MR. CLARKE:

Objection, irrelevant, hearsay.

263 THE COURT:

Sustained.

264 MR. NEUFELD:

Have you had an ongoing relationship with the Los Angeles Police Department's Scientific Investigation Division? "You" meaning Cellmark?

265 MR. CLARKE:

Objection, irrelevant.

266 THE COURT:

Overruled.

267 DR. COTTON:

Yes.

268 MR. NEUFELD:

You have worked on a number of cases with them?

269 DR. COTTON:

Yes.

270 MR. NEUFELD:

And they have talked to the laboratory director, Michele Kestler, from time to time?

271 DR. COTTON:

I haven't talked to her very often, but other lab staff have.

272 MR. NEUFELD:

And with respect to your familiarity with the LAPD laboratory, do you know to what extent they have any ph.D.s supervising the work product that comes out of that DNA laboratory?

273 MR. CLARKE:

Same objection.

274 THE COURT:

Sustained. It is also way beyond the scope of the direct examination.

275 MR. NEUFELD:

Now, has Cellmark worked with other laboratories in helping to generate standards for the processing of DNA evidence?

276 DR. COTTON:

No, we haven't. The group that generates standards or guidelines for the processing--for doing DNA analysis has mainly been TWGDAM and ASCLAD and Cellmark is not a member of the TWGDAM group because we are a business. And up until the point we were accredited we were not a member of the ASCLAD laboratory group or laboratory accreditation group and now we are, but that is very new.

277 MR. NEUFELD:

But even if there wasn't a formal relationship between Cellmark and the various forensic laboratories through scientific meetings and other types of informal gatherings, has Cellmark participated in the process and in the dialogue of trying to establish standards with the FBI and other entities for the processing of samples for DNA typing?

278 DR. COTTON:

We have more participated in the dialogue about scientific issues and we really were not included in the dialogue regarding guidelines for how typing should be done. Nonetheless, the guidelines are--it is apparent they didn't need our input because the guidelines are very good.

279 MR. NEUFELD:

Dr. Cotton, you mentioned already that you are familiar with Dr. Henry Lee. Are you familiar--are you familiar with a Dr. Gaensslen?

280 DR. COTTON:

Yes.

281 MR. NEUFELD:

And who is he?

282 DR. COTTON:

He is a forensic scientist. I believe he is on the faculty either at Yale or Connecticut and he is also the editor of the journal--the current editor of the "Journal of forensic science."

283 MR. NEUFELD:

So is he a respected member of the forensic science community?

284 DR. COTTON:

Yes, very respected.

285 MR. NEUFELD:

Are you also familiar with James Kearney or Kerney?

286 DR. COTTON:

Yes.

287 MR. NEUFELD:

Who is James Kearney?

288 DR. COTTON:

He is an FBI agent who has been involved in DNA analysis or supervising the--initially supervising the development of the methods that are used at the FBI for DNA analysis.

289 MR. NEUFELD:

In fact, wasn't he the Chief of Forensic Science Research and Training at the FBI Center at Quantico?

290 DR. COTTON:

Yes, that is good. I couldn't remember his exact title.

291 MR. NEUFELD:

And have you read the publication by the FBI entitled "Guidelines for the collection and preservation of DNA evidence"?

292 MR. CLARKE:

Objection, relevance, your Honor.

293 THE COURT:

Overruled.

294 DR. COTTON:

Yes, I have.

295 MR. NEUFELD:

And you are aware that the authors of this publication by the FBI are Dr. Henry Lee, Dr. Gaensslen and James Kearney from the FBI?

296 DR. COTTON:

Oh, maybe I need to look at what you are referring to, because what I'm thinking of doesn't have just three authors.

297 MR. NEUFELD:

Well, there is a fourth author, P. David Bigby as well.

298 DR. COTTON:

No, I don't think we are thinking of the same thing.

299 MR. NEUFELD:

May I approach the witness?

300 THE COURT:

You may.

301 (Brief pause.)
302 MR. CLARKE:

I'm sorry, may I see it, your Honor?

303 MR. NEUFELD:

It is already in evidence.

304 THE COURT:

Either counsel may approach the witness without leave of the Court.

305 (Brief pause.)
306 (Discussion held off the record between Deputy District Attorney and Defense counsel.)
307 MR. NEUFELD:

This is a photocopy. This isn't the original publication, looks like, in format.

308 (Brief pause.)
309 DR. COTTON:

I haven't read this.

310 MR. NEUFELD:

You haven't?

311 DR. COTTON:

No.

312 MR. NEUFELD:

Okay. Thank you. As a person who is the director of a forensic DNA laboratory, are you concerned with issues that involve the preservation and collection of biological samples so they will be able to be tested on a DNA level?

313 DR. COTTON:

Yes, I guess so.

314 MR. NEUFELD:

Would you agree that the ability to perform successful DNA analysis on biological evidence recovered from a crime scene depends very much on what kinds of specimens were collected and how they were preserved?

315 DR. COTTON:

Yes.

316 MR. NEUFELD:

And would you agree, Dr. Cotton, that if the DNA evidence is not properly documented prior to its collection, its origin could be questioned?

317 MR. CLARKE:

Objection, relevance, beyond the scope.

318 THE COURT:

Sustained.

319 MR. NEUFELD:

Dr. Cotton, you testified on direct examination as to the types of controls utilized by Cellmark in documenting each item of evidence that you process; is that correct?

320 MR. CLARKE:

Objection, misstates the evidence.

321 THE COURT:

Overruled.

322 DR. COTTON:

You have controls to assess how your scientific procedure worked, if that is what you are referring to then.

323 MR. NEUFELD:

Well, didn't you also say that there were certain rigorous documentation requirements, such as documenting every transfer of a biological specimen within the laboratory?

324 DR. COTTON:

There are rigorous documentation requirements. I didn't say that every transfer--and I'm using that term broadly, like we don't write down it is now going to the freezer, you know, stuff like that.

325 MR. NEUFELD:

Fine, but if it goes from one package to another package, is that the kind of thing that you have a rigorous requirement that it be documented?

326 DR. COTTON:

If the sample goes--when it gets transferred from one tube to the next once the processing has started, that transfer--that labeling is witnessed. That is, let me be totally clear. If I were working at the bench, I would hold up a tube with a label that said--would have the case number on it and it would be 02 and I would show my partner the second tube I was going to use which would be empty and it would also have the same case number and 02. I might then turn around and the actual transfer might not be witnessed, but we are concerned that the labeling is correct, so it is the labeling that is witnessed, not the actual necessarily the actual moving of the sample.

327 MR. NEUFELD:

Would it be fair to say that the reason you are so concerned and you even have a witness there, is because if the labeling isn't correct, the origin of the ultimate sample that you test may be called into question?

328 DR. COTTON:

Yes.

329 MR. NEUFELD:

And so would you agree likewise that if the evidence itself is not properly labeled and documented in the same way that you just described it at Cellmark, prior to its receipt at Cellmark, its origin can also be questioned?

330 MR. CLARKE:

Objection, irrelevant and beyond the scope.

331 THE COURT:

Sustained.

332 MR. NEUFELD:

Based on your expertise in working with forensic specimens, Dr. Cotton, would you agree that if a sample is not properly packaged cross-contamination might occur?

333 MR. CLARKE:

Objection, vague to as to time.

334 THE COURT:

Sustained. Rephrase the question.

335 MR. NEUFELD:

Well, Dr. Cotton, based on your expertise with forensic specimens, would you agree that if an item of biological evidence is not properly packaged in the first instance when it is collected, that cross-contamination might occur?

336 MR. CLARKE:

Objection, beyond the scope, irrelevant.

337 THE COURT:

It is vague.

338 MR. NEUFELD:

Dr. Cotton, based on your experience in handling and processing forensic specimens, are there certain do's and don'ts with respect to the packaging of biological specimens to preserve the DNA integrity?

339 MR. CLARKE:

Objection, vague.

340 THE COURT:

Overruled. Are there any guidelines that you are aware of, general guidelines, regarding these items?

341 DR. COTTON:

I'm not aware of any general guidelines. I am aware of how things are commonly done, since I am aware of the types of things that we receive in the laboratory, but I don't have any special expertise in collection of samples, so my knowledge is pretty much limited to what I am aware of that arrives at our laboratory.

342 MR. NEUFELD:

But is your knowledge also based on your--your common sense as an experienced forensic scientist? Is that a fair statement?

343 DR. COTTON:

Well, of course.

344 MR. NEUFELD:

And that as an experienced forensic scientist used to handling forensic specimens and reading literature on the subject, you have an appreciation of what--what proper controls should be followed when evidence is initially packaged, don't you?

345 MR. CLARKE:

Objection, vague.

346 THE COURT:

Sustained. Counsel, the problem there is "Controls."

347 MR. NEUFELD:

Based on your experience as a forensic scientist, haven't you arrived at certain conclusions and opinions as to what is the proper methods for packaging items of biological evidence at a crime scene in order to preserve it for DNA testing at your laboratory?

348 MR. CLARKE:

Same objection also, beyond the scope.

349 THE COURT:

Overruled. Overruled.

350 DR. COTTON:

I have some basic opinions about what common sense would tell you to do, and beyond that--and I also have some technical information about I know something about--giving you a very brief example, if something is dry, it is better than being stored wet, things like that.

351 MR. NEUFELD:

Okay.

352 DR. COTTON:

The things that I know affect DNA, but there is a limit.

353 MR. NEUFELD:

Fine. So I'm only going to ask you questions about what you know about and how it affects DNA, Dr. Cotton. Would you agree that when something is wet one should not package it in a sealed plastic bag?

354 DR. COTTON:

I wouldn't want to package it in a sealed plastic bag for days. I don't think it would make any difference if it were a short time, but I wouldn't want it to be in there for a long time unless it was cold.

355 MR. NEUFELD:

Are you aware of any forensic laboratory protocol that you have ever inspected that authorizes the packaging of wet biological samples in a sealed plastic bag even for a short time?

356 MR. CLARKE:

Objection, irrelevant, calls for hearsay.

357 THE COURT:

Sustained.

358 MR. NEUFELD:

Dr. Cotton, in your capacity as the laboratory director of a forensic DNA laboratory, have you on occasion inspected the protocols of other forensic DNA laboratories?

359 MR. CLARKE:

Same objection.

360 THE COURT:

Overruled.

361 DR. COTTON:

I have, but that would only be with regard to the DNA typing procedure protocols. That is, what--how you do the DNA analysis, and I have not inspected or read any other types of protocols from a forensic lab.

362 (Discussion held off the record between Defense counsel.)
363 MR. NEUFELD:

Now, Dr. Cotton, in this case a criminalist has testified that she placed wet blood swatches in a clear plastic bag which is folded over so the swatches are less likely to fall out. Would you agree, Dr. Cotton, that by putting a wet swatch into a closed plastic bag that that allows the moisture to remain in the swatch?

364 MR. CLARKE:

Same objection as to beyond the scope.

365 THE COURT:

Overruled.

366 DR. COTTON:

If the plastic bag is sealed like a zip-lock, where it is airtight, then that might be a problem. If it is just folded over, it might not be a problem.

367 MR. NEUFELD:

Dr. Cotton, if the--

368 MR. CLARKE:

I'm sorry, I'm not sure the witness finished her answer.

369 MR. NEUFELD:

I'm sorry. Had you finished?

370 THE COURT:

I think she finished.

371 DR. COTTON:

I am finished.

372 MR. NEUFELD:

Dr. Cotton, if it is folded over such that wet blood in the plastic bag allows the two sides of the plastic bag to adhere to one another, wouldn't that retain moisture?

373 DR. COTTON:

I don't really know. I haven't seen this plastic bag. I've given you the fullest extent of an answer that I think I can.

374 MR. NEUFELD:

One moment, your Honor.

375 (Brief pause.)
376 MR. NEUFELD:

Dr. Cotton, while we are getting the plastic bags that are in evidence, based on your common sense and your experience as an expert, would you agree that a small piece of cotton, perhaps four or five millimeters, by four or five millimeters, if it is dabbed in wet blood, would in ordinary circumstances dry within minutes?

377 MR. CLARKE:

Well, objection at this point, no foundation, beyond the scope.

378 THE COURT:

Sustained.

379 MR. NEUFELD:

Would you agree, Dr. Cotton--

380 THE COURT:

Counsel, isn't the issue that we need to address with Dr. Cotton, is the impact of moisture, heat, age on the degradation process of DNA? Isn't that the issue?

381 MR. NEUFELD:

I believe it is, your Honor.

382 THE COURT:

All right. Then why don't we ask those questions directly.

383 MR. NEUFELD:

Would you agree, Dr. Cotton, that moisture promotes bacterial growth?

384 DR. COTTON:

Yes.

385 MR. NEUFELD:

Would you agree, Dr. Cotton, that bacteria starts eating up the DNA and the DNA deteriorates and degrade?

386 DR. COTTON:

Over time, yes.

387 MR. NEUFELD:

Would you agree, Dr. Cotton, that degradation occurs more quickly under the combined effects of moisture and heat?

388 DR. COTTON:

Yes, I would.

389 MR. NEUFELD:

In your laboratory, Dr. Cotton, where you are the laboratory director, would it be scientifically acceptable to let wet plastic stains remain in sealed plastic bags--

390 THE COURT:

Would you want to rephrase that. You said "Wet plastic stains."

391 MR. NEUFELD:

Sorry. Because that is what I have written here. At least I can read correctly, your Honor. I just can't type correctly, I'm sorry.

392 THE COURT:

Let me do it.

393 MR. NEUFELD:

Dr. Cotton, in your laboratory would it be scientifically acceptable to let swatches of wet bloodstains remain in sealed plastic bags in the rear of a parked truck unrefrigerated and unair-conditioned in the middle of June for up to seven hours?

394 MR. CLARKE:

Objection, argumentative.

395 THE COURT:

Overruled.

396 DR. COTTON:

I don't think that would be my first choice, but please keep in mind that my laboratory doesn't collect evidence and so we don't collect it, we don't have a truck, we just receive it from someone else who has already collected it.

397 MR. NEUFELD:

And as a result of that, Dr. Cotton, there is no way that you can control the extent to which the offering agency either degraded those samples or cross-contaminated those samples; isn't that right?

KEY QUOTE
398 DR. COTTON:

Of course.

399 (Discussion held off the record between Defense counsel.)
400 MR. NEUFELD:

Dr. Cotton, I will now show you what has already been marked in evidence as Prosecution 163-e, the plastic bags used by Andrea Mazzola to collect the swatches. You notice how when it rests the two sides of the plastic bag actually lay one on top of the other; is that right?

401 DR. COTTON:

Yeah.

402 MR. NEUFELD:

And would you agree, Dr. Cotton, that if based on your experience with biological materials, that if five or six wet swatches were placed on the bottom of that bag, that the plastic would remain in a closed position, namely, the two sides would remain in contact with one another as opposed to in an opposition?

403 DR. COTTON:

That is probably correct.

404 MR. NEUFELD:

And in a closed position, would you agree, Dr. Cotton, that when in a closed position moisture is retained in the plastic bag, as opposed to having the sample drying?

405 DR. COTTON:

Yes.

406 THE COURT:

All right. Are we available to move on?

407 MR. NEUFELD:

I'm sorry, what?

408 THE COURT:

I think the jury got the point two weeks ago about the bags and wet swatches.

409 (Brief pause.)
410 THE COURT:

Actually, have we passed that bag through the jury box?

411 MR. NEUFELD:

Now--

412 THE COURT:

Counsel, given the size and the regular nature of the bag, I would just suggest we hand one of the bags to juror no. 1, she can pass it through, just one, and we can proceed with the testimony, since it is a small item to look at. Do you agree with that?

413 MR. NEUFELD:

That's fine.

414 THE COURT:

All right. Mr. Scheck, would you hand that to juror no. 1, please. Thank you. Proceed.

415 (The exhibit was passed amongst the jury.)
416 (Discussion held off the record between Deputy District Attorney and Defense counsel.)
417 (Discussion held off the record between Defense counsel.)
418 MR. NEUFELD:

Dr. Cotton, just so I'm--well, even though the swatch itself doesn't unravel, due to the degradation caused by heat and moisture, invisible changes are occurring; isn't that right?

419 MR. CLARKE:

Objection, vague.

420 THE COURT:

Stained. Rephrase the question.

421 MR. NEUFELD:

Well, when you finally remove a swatch from a plastic bag where it has been subjected continuously to heat and moisture, will the swatch still look the same, namely, will it still look as red as it did before it was subjected to the heat and humidity?

422 THE COURT:

Why don't you rephrase that question. I think are assuming facts that aren't in evidence in that hypothetical.

423 MR. NEUFELD:

Well--

424 THE COURT:

The problem is "Continually" subjected to heat. That is not in the record.

425 MR. NEUFELD:

If a swatch was placed in a hot truck in June and it wasn't air-conditioned, for up to seven hours and it remained during those seven hours moist, would the degrading process continue?

426 MR. CLARKE:

Objection, vague.

427 THE COURT:

Overruled.

428 DR. COTTON:

How hot are we talking about?

429 MR. NEUFELD:

Well, just from your own common experience, if an object is left in a black truck which absorbs heat rather than reflecting it--

430 THE COURT:

Hold on. We have an attorney from New York and we have an expert witness from Maryland talking about June weather conditions in Santa Monica. We got a problem here.

KEY QUOTE
431 MR. COCHRAN:

May I testify?

432 THE COURT:

No, you may not, mr. Cochran.

433 (Discussion held off the record between defense counsel.)
434 THE COURT:

All right. Deputy Long has and handed bag back to Miss Clark.

435 (Discussion held off the record between Defense counsel.)
436 MR. NEUFELD:

Your Honor, rather than even getting into that, I think the jury's recollection of how certain criminalists appeared on the videotape will be controlling on this point and I won't even proceed with it.

437 THE COURT:

Proceed.

438 MR. NEUFELD:

Okay.

439 MR. NEUFELD:

Umm, let me show you the swatches--

440 (Discussion held off the record between Defense counsel.)
441 MR. NEUFELD:

Would you simply agree, Dr. Cotton, that the warmer it is the more that exacerbates the degrading process?

442 DR. COTTON:

If there is bacteria present, the warmer it is, that's correct, until it gets too hot, at which point it would kill the bacteria also.

443 MR. NEUFELD:

And in fact if there is moisture present that also increases the likelihood of bacteria eating away at the DNA as well, doesn't it?

444 DR. COTTON:

Under most conditions that would be true, yes.

445 MR. NEUFELD:

And if a stain is lying on a sidewalk it would not be unlikely or unreasonable that there would be some bacteria present; isn't that right?

446 DR. COTTON:

Of course.

447 MR. NEUFELD:

Now, I would like to show you--

448 (Discussion held off the record between Defense counsel.)
449 MR. NEUFELD:

Dr. Cotton, I would like to two show you two photographs which I guess will be next in order.

450 THE COURT:

Have you shown those to Mr. Clark?

451 MR. NEUFELD:

Yes, yes.

452 THE COURT:

All right.

453 MR. NEUFELD:

He has a copy of them.

454 THE COURT:

All right. 1146, 1147 47.

455 (Deft's 1146 for id = photograph)
456 (Deft's 1147 for id = photograph)
457 (Discussion held off the record between Deputy District Attorney and Defense counsel.)
458 MR. NEUFELD:

May I approach the witness?

459 THE COURT:

You may. Counsel, if you are questioning the witness, feel free to approach the witness.

460 MR. NEUFELD:

Now, Dr. Cotton, do you remember that I think you said that Dr. Blake was present at the laboratory when certain samples were unpackaged?

461 DR. COTTON:

That's right.

462 MR. NEUFELD:

And when these samples were unpackaged, Dr. Blake took photographs of them, didn't he?

463 DR. COTTON:

Yes, he did.

464 MR. NEUFELD:

And I show you first--what was the next item, I'm sorry?

465 THE COURT:

1146.

466 MR. NEUFELD:

1146. Do you recognize what is in photograph--I'm sorry, item 1146?

467 DR. COTTON:

Yes, I do.

468 MR. NEUFELD:

And could you please tell us what it is?

469 DR. COTTON:

This is one of the items that was opened when Dr. Blake and Dr. Lee were at the laboratory and it consists of five swatches.

470 MR. NEUFELD:

And does those five swatches represent sample LAPD number item 47?

471 DR. COTTON:

Yes.

472 MR. NEUFELD:

And item 47 are purported to be stains taken from one of the drops at Bundy; isn't that correct?

473 DR. COTTON:

That's right.

474 MR. NEUFELD:

Now, I show you--and I ask the Court's indulgence. What is the next item?

475 THE COURT:

1147.

476 MR. NEUFELD:

1147.

477 THE COURT:

1147.

478 MR. NEUFELD:

I show you 1147 and ask you if you can recognize that photograph?

479 DR. COTTON:

Yes, I do.

480 MR. NEUFELD:

And please tell us what it is?

481 DR. COTTON:

It is the item number no. 12 that was also opened on that same day and it consists of six swatches.

482 MR. NEUFELD:

And is that a fair and accurate representation as to how the swatches appeared that day?

483 DR. COTTON:

Yes, it is.

484 MR. NEUFELD:

Your Honor, with the Court's permission may I exhibit them on the elmo?

485 THE COURT:

You may.

486 (Discussion held off the record between Defense counsel.)
487 THE COURT:

All right. Mr. Neufeld, which photograph--these are both side-by-side?

488 MR. NEUFELD:

Yes.

489 THE COURT:

All right. You showed to the witness as to each one of these, 1146 and 1147, a group of three photographs.

490 MR. NEUFELD:

Yes, but I'm--since one photograph is simply the external envelope, I didn't feel the need to show that.

491 THE COURT:

All right. Are you offering those as a group of three or just these two photographs?

492 MR. NEUFELD:

Just these two photographs.

493 THE COURT:

All right. Proceed.

494 MR. NEUFELD:

Okay.

495 THE COURT:

Can you get that focused a little better?

496 (Brief pause.)
497 THE COURT:

All right. Mr. Neufeld.

498 MR. NEUFELD:

Now, just--now, you obviously know what the markings are on these different photographs, Dr. Cotton, or you may know, but just from looking at those photographs, for instance, can you tell which swatches came from item 47 and which swatches came from item 12?

499 DR. COTTON:

No.

500 MR. NEUFELD:

And would it be fair to say that as you look at the swatches that purport to be item 47 and purport to be item 12 that you can't tell which ones are very degraded and which ones aren't?

501 DR. COTTON:

That's right.

502 MR. NEUFELD:

And in fact, Dr. Cotton, I believe you said that--well, let--let the record reflect that the upper photograph represents the swatches from item 47--that purport to be item 47.

503 THE COURT:

1146.

504 MR. NEUFELD:

Right.

505 MR. NEUFELD:

And that the lower group of swatches in this picture, which would be 11--

506 THE COURT:

47.

507 MR. NEUFELD:

--47 purport to be the swatches from item no. 12.

508 (Discussion held off the record between Defense counsel.)
509 MR. NEUFELD:

And based on your testimony, you would agree that there is a lot more DNA present in the swatches from item 12, which is the bottom photograph, than there is in item 47, represented by the top photograph?

510 MR. CLARKE:

Objection, vague.

511 THE COURT:

Overruled.

512 DR. COTTON:

Yes, that is correct. Well, the DNA is in better condition in item 47 than item 12. I haven't compared--I would probably have to go back and think about a comparison for the precise amounts of DNA.

513 MR. NEUFELD:

Well, Dr. Cotton, in fact you said one of the ways that you assess the precise amount or approximate the amount is to do a slot-blot, correct?

514 DR. COTTON:

Yes. Did I just say that backwards? Item 12 is in better condition than item 47.

515 THE COURT:

The jurors are nodding yes, you had that backwards.

516 MR. NEUFELD:

One of the ways that you determine the quantity of human DNA that is present is through a slot-blot, correct?

517 DR. COTTON:

Yes.

518 MR. NEUFELD:

And did do you a slot-blot on both item 12 and item 47?

519 DR. COTTON:

Probably.

520 MR. NEUFELD:

Could you check your notes and please tell us what result you obtained for item 12?

521 DR. COTTON:

Yes. It will take me a minute.

522 MR. NEUFELD:

Please do.

523 (Brief pause.)
524 (Discussion held off the record between Defense counsel.)
525 THE COURT:

Mr. Neufeld, we are going to break at 10:30.

526 MR. NEUFELD:

Break at 10:30?

527 THE COURT:

10:30.

528 (Brief pause.)
529 DR. COTTON:

Are you asking me how much--

530 MR. NEUFELD:

One moment.

531 DR. COTTON:

Oh, I'm sorry.

532 (Brief pause.)
533 THE COURT:

Is it me or is it a little warm in here? Apparently our power department here had a power surge, which was what that glitch was. Apparently our air conditioning system went down with that so I'm having Mrs. Robertson check, so if you want to stand up and take your jacket off, be my guest. Let's proceed. I thought it was just me.

534 MR. NEUFELD:

I don't know what would give you that idea, your Honor. By the way, may we mark this printout as Defendant's 1148?

535 THE COURT:

Yes. Side-by-side?

536 MR. NEUFELD:

Yes.

537 THE COURT:

Yes. 1148.

538 (Deft's 1148 for id = photograph)
539 MR. NEUFELD:

Have you had a chance to look at the slot-blot for item 12?

540 DR. COTTON:

Yes, I have.

541 MR. NEUFELD:

And by the way, does that slot-blot represent ten percent of the whole sample or is it again ten percent of the portion that was set aside for PCR testing which is approximately ten percent of the whole sample, or if it is something completely different than both of those, please explain what it represents.

542 DR. COTTON:

The slot-blot is giving us information about the DNA in the ten percent of the sample that was set aside for PCR testing.

543 MR. NEUFELD:

But the portion that you use in the slot-blot, is it ten percent--is it a ten percent solution of that ten percent?

544 DR. COTTON:

That's right.

545 MR. NEUFELD:

So really then the slot-blot is approximately one percent of the entire sample, approximately; is that right?

546 DR. COTTON:

Yes.

547 MR. NEUFELD:

Okay. Now, what was the slot-blot reading you got for the amount of human DNA present in item 12?

548 DR. COTTON:

For the amount that was loaded on the slot-blot, my estimation is this is approximately ..5 nanograms.

549 MR. NEUFELD:

So--

550 (Discussion held off the record between Defense counsel.)
551 MR. NEUFELD:

Now, did you also do a slot-blot for item 47?

552 DR. COTTON:

Yes.

553 MR. NEUFELD:

And could you please tell the jury what you came up with for the slot-blot on item 47?

554 DR. COTTON:

Yes. I have to take the same time to do that.

555 (Brief pause.)
556 DR. COTTON:

Okay.

557 MR. NEUFELD:

Okay. Isn't it a fact, Dr. Cotton, that for item 47, when you ran that slot-blot, the amount of DNA observed was zero?

558 DR. COTTON:

That's what the slot-blot is saying, yes.

559 MR. NEUFELD:

Thank you. Yet--

560 DR. COTTON:

That doesn't mean that there is none there. It means that this measure can't detect any.

561 MR. NEUFELD:

Did you conduct any other test to assess quantitatively the amount of human DNA present in the sample?

562 DR. COTTON:

In 47?

563 MR. NEUFELD:

Yes.

564 DR. COTTON:

No.

565 MR. NEUFELD:

Okay. And would you agree that notwithstanding the disparity between the .5 and zero, those differences would not be observed when you look at these swatches before they are tested?

566 DR. COTTON:

Yes, that's right.

567 (Discussion held off the record between Deputy District Attorney and Defense counsel.)
568 MR. NEUFELD:

Now, in a hypothetical that Mr. Clarke gave you on direct examination, he talked about the possibility--

569 (Discussion held off the record between Deputy District Attorney and Defense counsel.)
570 MR. NEUFELD:

He talked about--he asked you to assume that item 47 was a bloodstain found in an area that had soil and leaves in it. Do you recall that?

571 MR. CLARKE:

Objection, misstates the evidence.

572 THE COURT:

Overruled.

573 MR. NEUFELD:

Do you recall that?

574 MR. CLARKE:

I'm sorry. May we be heard on this, your Honor?

575 THE COURT:

Do you have the transcript cite?

576 MR. NEUFELD:

I do not have the transcript cite, your Honor. That is my recollection. If you want--if you want to take the recess now, I could find that citation during the recess.

577 THE COURT:

All right. Let's do that. All right. Ladies and gentlemen, I'm going to take our morning recess at this time. Please remember all my admonitions to you. Don't discuss the case among yourselves, form any opinions about the case, don't allow anybody to communicate with you, do not conduct any deliberations until the matter has been submitted. And we will see you back in about fifteen minutes. All right. Dr. Cotton, you can step down.

Temperature

tense

Key Quotes (5)

Dr. Robin Cotton
Cellmark is paid for my attendance here. I don't get paid.
Cotton distinguishes herself from the financial arrangement, but confirms Cellmark charges $1200/day for her testimony — establishing the for-profit bias Neufeld was building toward.
Peter Neufeld
would it be scientifically acceptable to let swatches of wet bloodstains remain in sealed plastic bags in the rear of a parked truck unrefrigerated and unair-conditioned in the middle of June for up to seven hours?
The central hypothetical of the cross — directly targeting the LAPD's evidence collection and storage procedures and their effect on DNA integrity.
Dr. Robin Cotton
Of course. And as a result of that, Dr. Cotton, there is no way that you can control the extent to which the offering agency either degraded those samples or cross-contaminated those samples; isn't that right?
Cotton concedes Cellmark has no ability to control or verify what happened to samples before they arrived — a significant admission undermining confidence in the chain of custody.
Lance A. Ito
We have an attorney from New York and we have an expert witness from Maryland talking about June weather conditions in Santa Monica. We got a problem here.
Ito cutting through Neufeld's hypothetical about truck temperatures with characteristic dry wit, but effectively blocking a line of questioning.
Johnnie Cochran
May I testify?
Cochran's quip in response to Ito's observation about geographic expertise, prompting Ito's immediate 'No, you may not.'

Evidence (6)

Defense 1145
Five-page letter shown to Cotton the previous afternoon, related to scientific debate over population genetics independence assumptions used in forensic DNA typing
discussed — Cotton confirmed she read it but did not rely on it in forming her opinions
Informal
NRC book 'DNA Technology in Forensic Science' — Cotton had her own copy
discussed extensively — used to establish credibility of committee members critical of forensic DNA methods
Informal
FBI publication 'Guidelines for the Collection and Preservation of DNA Evidence' by Lee, Gaensslen, Kearney, and Bigby
approached witness — Cotton said she had not read this particular document
Prosecution 163-e
Plastic bags used by criminalist Andrea Mazzola to collect blood swatches
physically shown to witness and passed through jury box — used to demonstrate moisture retention when bag sides lie flat against each other
Defense 1146
Photograph of five swatches from LAPD item 47 (purported Bundy drop stains), taken by Dr. Blake when samples were opened at Cellmark with Dr. Lee present
introduced and displayed on ELMO — used to compare degradation visually between items
Defense 1147
Photograph of six swatches from LAPD item 12, also opened at Cellmark in presence of defense experts
introduced and displayed on ELMO — Cotton confirmed item 47 swatches had DNA in better condition than item 12 swatches

Notable Exchanges (4)

Peter NeufeldDr. Robin Cotton
Neufeld methodically established that Cellmark charges $1200/day for Cotton's testimony, charged the defense over $5,000 for discovery materials including $25/autorad (vs. implied lower government rates), and is a for-profit business — building a financial bias argument.
strategic
Peter NeufeldDr. Robin Cotton
Neufeld pressed Cotton on whether blind external proficiency testing was necessary before a lab goes online with DNA typing. Cotton disagreed it was necessary pre-launch, citing the logical impossibility of blind trials before accepting cases, and acknowledged Cellmark does 'not very many' external blind tests.
revealing
Peter NeufeldDr. Robin CottonLance A. Ito
Extended debate over the plastic bags used to store wet blood swatches. Ito intervened to redirect Neufeld to the core scientific question (moisture/heat/degradation) and eventually had the bag passed through the jury while commenting that 'the jury got the point two weeks ago.'
procedural
Peter NeufeldLance A. ItoJohnnie Cochran
Neufeld's hypothetical about June heat in a black truck was interrupted by Ito noting the absurdity of a New York lawyer and Maryland expert speculating about Santa Monica weather. Cochran offered to testify; Ito declined. Neufeld ultimately abandoned the line.
light

Light Moments (4)

Johnnie Cochran
Cochran offered to testify about Santa Monica June weather after Ito noted neither Neufeld (NY) nor Cotton (MD) had standing to speculate about local conditions. Ito: 'No, you may not, Mr. Cochran.'
Lance A. Ito
Ito told the jury Cotton could explain blind proficiency tests after a power outage interrupted her mid-sentence: 'You're welcome.'
Peter Neufeld
Neufeld apologized for a typo in his notes that produced the phrase 'wet plastic stains': 'At least I can read correctly, your Honor. I just can't type correctly, I'm sorry.'
Lance A. Ito
Ito dryly observed 'I think the jury got the point two weeks ago about the bags and wet swatches' while Neufeld was still working through the plastic bag demonstration.

Credibility Attacks (3)

⚔ Dr. Robin Cotton / Cellmark
financial bias
Neufeld established Cellmark is a for-profit business charging $1200/day for Cotton's testimony, charged the defense over $5,000 for discovery materials, and charges $25/autorad — suggesting Cellmark has a financial stake in the acceptance of forensic DNA typing methodology.
⚔ LAPD evidence handling (via Cotton)
expert concession
Neufeld elicited Cotton's agreement that moisture and heat accelerate bacterial DNA degradation, that storing wet swatches in sealed plastic bags is not ideal, and critically that Cellmark has no ability to control or audit how the submitting agency collected, packaged, or stored evidence before delivery — undermining the integrity of all LAPD-sourced samples.
⚔ Forensic DNA industry generally
absence of mandatory regulation
Cotton confirmed there is no federal regulatory scheme governing the quality of forensic DNA profiling at any laboratory, that ASCLD accreditation is voluntary, and that external blind proficiency testing is not mandatory — contrasting with Cotton's earlier direct testimony emphasizing Cellmark's quality controls.

Witness Demeanor

(Brief pause.) (Power outage in the courtroom.)
(Discussion held off the record between Defense counsel.) [multiple instances, suggesting Neufeld consulting with Scheck]
Cotton asked 'Can I finish, please?' when Neufeld cut off her answer about discovery charges — showing mild firmness under cross.

Objections

27 objections (17 sustained, 10 overruled)
Proceeding 7904 • 577 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 12, 1995 📄 Cross-examination of Dr. Robin
MAY 12, 1995 KRT DvH TD